NAD level

Speaker 1...so it's really about the intracellular NAD⁺ status – how much of this specific molecule, NAD, is present inside our cells.

Speaker 2And why is that important for longevity research? What makes NAD a focus for scientists?

Speaker 1Well, NAD, or nicotinamide adenine dinucleotide, plays a critical role in numerous cellular processes. Think of it as a crucial coenzyme involved in metabolism, DNA repair, and even gene expression. It's fundamental to how our cells function and maintain themselves.

Speaker 2So, if NAD levels are high, our cells are potentially functioning better, which could lead to better health outcomes over time?

Speaker 1That's the hypothesis many researchers are exploring. Studies have shown that NAD levels naturally decline with age. For instance, research published in *Nature Metabolism* in 2020 highlighted this age-related decline and its potential implications.

Speaker 2But what’s still unknown? Are we sure that boosting NAD levels directly extends human lifespan or healthspan?

Speaker 1That’s a key question. While animal studies have shown promising results in improving various age-related markers and even extending lifespan, we don't have definitive human evidence yet for direct longevity extension. It's an active area of research. We understand its role, and we see the decline, but the causal link for humans is still being established.

Speaker 2So, scientists are essentially looking at NAD levels as a biomarker, a potential indicator of biological age or cellular health, rather than a proven fountain of youth right now.

Speaker 1Exactly. It's a significant area of interest because it touches so many fundamental biological processes that are linked to aging.

Speaker 1...and this is why human evidence is so crucial. We see a lot of excitement around NAD boosters, based on animal studies, but human trials often tell a more nuanced story.

Speaker 2Exactly. Take NMN or NR, for example. They're precursors to NAD, which is vital for cellular energy and repair. In mice, supplementing these often shows incredible benefits, like improved metabolism or extended lifespan. But humans? It’s not always a direct translation.

Speaker 1Right. A lot of the early human trials on NAD precursors focused on safety and pharmacokinetics, showing they *do* increase NAD levels. For instance, a 2023 study in *Cell Metabolism* showed NR supplementation increased NAD+ in blood cells. But what about the *functional* outcomes? Do these increased levels actually lead to measurable health benefits in healthy people?

Speaker 2That's where it gets complicated. We're starting to see some promising, but small, studies. One in *Nature Communications* in 2027 indicated NR improved some metabolic markers in a specific population with insulin resistance. But for broader anti-aging claims in the general population, the evidence is still very limited. Many large, robust trials are still ongoing.

Speaker 1And importantly, some trials show null results. Not every study finds a significant improvement in health or aging biomarkers, even when NAD levels go up. This doesn't mean it's useless, but it underscores that we still don't fully understand the optimal dosage, target populations, or long-term effects.

Speaker 2Precisely. It’s a powerful example of why we need to separate the scientific potential from the current marketing hype, and really look at what the clinical trials, including those without dramatic findings, are telling us.